veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immunseren und immunglobuline, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immunseren und immunglobuline, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
xevudy konzentrat zur herstellung einer infusionslösung
glaxosmithkline ag - sotrovimabum - konzentrat zur herstellung einer infusionslösung - lösung: sotrovimabum 500 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, aqua ad iniectabile q.s. ad solutionem pro 8 ml. - behandlung von covid-19 - biotechnologika
paracetamol accord 1000 mg brausetabletten
accord healthcare b.v. - paracetamol -
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
evusheld injektionslösung
astrazeneca ag - tixagevimabum, cilgavimabum - injektionslösung - a): tixagevimabum 150 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 1.5 ml. b): cilgavimabum 150 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 1.5 ml. - behandlung und prä-expositionsprophylaxe von covid-19 - biotechnologika